Literature DB >> 2337681

Correlations between cytogenetics and morphology in myelodysplastic syndromes.

L Vila1, C Charrin, E Archimbaud, D Treille-Ritouet, J Fraisse, P Felman, D Fiere, D Germain.   

Abstract

In order to detect possible relationships between cytogenetic abnormalities and morphologic features in myelodysplastic syndromes (MDS), 48 patients with MDS were investigated. Clonal cytogenetic abnormalities were present in bone marrow cells from 27 patients (56%). The most frequent single anomaly was del (5 q) (10 cases), followed by monosomy 7 (3 cases), trisomy 8 (3 cases) and del (20 q) (2 cases). Complex anomalies were present in 6 patients. Morphologically, according to the French-American-British (FAB) classification: 17 cases were considered as refractory anemia (RA), 17 as RA with excess of blasts (RAEB), 2 as RAEB in transformation, 2 as acquired idiopathic sideroblastic anemia and 10 as chronic myelomonocytic leukemia. With regard to the FAB classification, del (5 q) was often associated with RA and complex cytogenetic anomalies with RAEB. When myelodysplasia was studied in individual myeloid lineages, del (5 q) was associated with hypolobulated megakaryocytes, monosomy 7 with micromegakaryocytes and complex chromosomal anomalies with the association of two or more features of dysmegakaryocytopoiesis. Del (11 q) was associated with increased iron storage and del (20 q) with marked dyserythropoiesis. No correlation was observed between cytogenetic anomalies and features of dysgranulocytopoiesis.

Entities:  

Mesh:

Year:  1990        PMID: 2337681     DOI: 10.1007/bf01728788

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  25 in total

1.  [A new technic of analysis of the human karyotype].

Authors:  B Dutrillaux; J Lejeune
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1971-05-17

2.  Prognostic factors in chronic myelodysplastic syndromes: a multivariate analysis in 107 cases.

Authors:  S García; M A Sanz; V Amigo; P Colomina; M D Carrera; J I Lorenzo; G F Sanz
Journal:  Am J Hematol       Date:  1988-03       Impact factor: 10.047

3.  Hematologic manifestations associated with deletions of the long arm of chromosome 20.

Authors:  M P Davis; G W Dewald; R V Pierre; H C Hoagland
Journal:  Cancer Genet Cytogenet       Date:  1984-05

4.  [Induced leukemias. Cytogenetical and cytological aspects. Comparison with primitive leukemias (author's transl)].

Authors:  R Berger; A Bernheim; M T Daniel; F Valensi; G Flandrin
Journal:  Nouv Rev Fr Hematol       Date:  1981

Review 5.  The 5q-anomaly.

Authors:  H Van den Berghe; K Vermaelen; C Mecucci; D Barbieri; G Tricot
Journal:  Cancer Genet Cytogenet       Date:  1985-07

6.  Myelodysplastic syndromes: analysis of 131 cases according to the FAB classification.

Authors:  T Economopoulos; N Stathakis; A Foudoulakis; N Papadoulis; J Dervenoulas; E Papageorgiou; C Anastassiou; J Hadjioannou; S Raptis
Journal:  Eur J Haematol       Date:  1987-04       Impact factor: 2.997

7.  Haematological features of primary myelodysplastic syndromes (PMDS) at initial presentation: a study of 118 cases.

Authors:  S K Juneja; M Imbert; H Jouault; J Y Scoazec; F Sigaux; C Sultan
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

8.  Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia.

Authors:  J J Yunis; M Lobell; M A Arnesen; M M Oken; M G Mayer; R E Rydell; R D Brunning
Journal:  Br J Haematol       Date:  1988-02       Impact factor: 6.998

9.  Myelodysplastic syndromes: analysis of morphological features related to the FAB-classification.

Authors:  M van der Weide; W Sizoo; J Krefft; M M Langenhuijsen
Journal:  Eur J Haematol       Date:  1988-07       Impact factor: 2.997

10.  Application of megakaryocytic morphology in diagnosing 5q- syndrome.

Authors:  T Thiede; L Engquist; R Billström
Journal:  Eur J Haematol       Date:  1988-11       Impact factor: 2.997

View more
  1 in total

Review 1.  Diagnostics and Prognostication of Myelodysplastic Syndromes.

Authors:  Gina Zini
Journal:  Ann Lab Med       Date:  2017-11       Impact factor: 3.464

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.